Exceptional teams with proven track records are building the next generation generics company. Lotus product portfolio consists of a broad range of leading molecules for the treatment for oncology, central nervous system, cardiovascular diseases, woman health care, and anti-obesity.
For our products in Korea, please download product brochure of Alvogen Korea:
Lotus has operations in 10 countries within Asian region through its own and Alvogen’s affiliates, with manufacturing and R&D capabilities in Taiwan and Korea.
Connect with local teams to learn more about product offering in your region.